Alphamab Oncology (HKG:9966) said it received a waiver from the Hong Kong stock exchange to allow Cheng Qiulan to be appointed as company secretary, according to a Tuesday filing with the Hong Kong bourse.
The bourse earlier deemed Cheng is not experienced enough or qualified for the position. The three-year waiver request states that Chan Lok Yee will assist Cheng during this period.
The waiver may be revoked if there are any material violations of the terms, the filing added.
Price (HKD): $3.96, Change: $+0.0100, Percent Change: +0.25%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.